Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-13

Clinical Trial Update: Effect of Daily Glucomannan in Overweight Patients [Phase 4]

View source ↗

Summary

This clinical trial update reports on a Phase 4 study evaluating daily glucomannan in overweight and obese individuals; the current status of the trial is unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glucomannan (glucomannan)

Snippet

Sponsor: ProMedica Health System | Conditions: Overweight, Obesity | Phase 4 | Status: UNKNOWN